Genome Editing Market Trends, Business Strategies and Opportunities With Key Players Analysis 2030
Data Bridge Market Research analyses that the global genome
editing market, which was USD 5,512.13 million in 2022, is
expected to reach USD 18,400.23 million by 2030 and is expected to undergo a
CAGR of 17.2% during the forecast period of 2023 to 2030. "CRISPR"
dominates the technology segment of the global genome editing market due to the
rising demand for genome editing. In addition to the insights on market scenarios
such as market value, growth rate, segmentation, geographical coverage, and
major players, the market reports curated by the Data Bridge Market Research
also include depth expert analysis, patient epidemiology, pipeline analysis,
pricing analysis, and regulatory framework.
Market research analysis data included in this report lend a
hand to businesses for planning of strategies related to investment, revenue
generation, production, product launches, costing, inventory, purchasing and
marketing. What's more Genome Editing Market report presents the data and
information for actionable, most recent and real-time market insights which
makes it easier to even take critical business decisions.
Download
Copy of this Report to understand structure of the complete @ https://www.databridgemarketresearch.com/reports/global-genome-editing-market
Market
Definition:
Genome editing is a technique for precisely altering an organism's
or cell's DNA. It is used to alter any organism's genome. It uses a special
kind of enzyme called an "engineered nuclease" that makes a precise
cut in the genome. A specific region of the DNA is cut, and the cell
automatically heals the damage. It has uses in various fields, including
agriculture, biotechnology, medicines, and mutation. The prevalence of chronic
and infectious diseases will probably increase, broadening the application of
genome editing.
Market
Overview:
Genome editing is a relatively new technique for changing
specific DNA sequences. It has become common practice in fundamental biomedical
research to examine gene function by modifying genomes using the bacterial
immune system, a potent tool for genome editing. This technology is
increasingly used in studying and treating human diseases by altering human
blood cells injected into the body to cure various diseases, such as cystic
fibrosis, cancer, and AIDS.
Market
Scope and Size:
The global genome editing market is segmented on the basis of
technology, application, product and service, method, and end user. The growth
amongst these segments will help you analyze meagre growth segments in the
industries and provide the users with a valuable market overview and market insights
to help them make strategic decisions for identifying core market applications.
Technology
- CRISPR
- TALEN
- ZFN
- ANTISENSE
- Other
Technologies
Application
- Cell
Line Engineering
- Genetic
Engineering
- Diagnostic
Applications
- Drug
Discovery and Development
- Other
Applications
Product and Service
- Reagents
- Consumables
End User
- Pharmaceutical
and Biopharmaceutical Industry
- Biotechnology
Industry
- Academic
Institutions
- CROs
- Government
Research Organizations
- Others
Method
- Ex-Vivo
- In-Vivo
Country
Level Analysis:
The countries covered in the global genome editing market
report are U.S., Canada and Mexico, Germany, France, U.K., Netherlands,
Switzerland, Belgium, Russia, Italy, Spain, Turkey, rest of Europe in Europe,
China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand,
Indonesia, Philippines, rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC),
Saudi Arabia, U.A.E., South Africa, Egypt, Israel, rest of Middle East and
Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina, and
rest of South America as part of South America.
Key
Players:
Some of the major players operating in the global genome
editing market are:
·
Merck KGaA (Germany)
·
GenScript (China)
·
Sangamo Therapeutics (U.S.)
·
Lonza (Switzerland)
·
Editas Medicine (U.S.)
·
CRISPR Therapeutics (Switzerland)
·
Tecan Trading AG (Switzerland)
·
Precision Biosciences (U.S.)
·
PerkinElmer Inc. (U.S.)
·
Cellectis S.A (France)
·
Genome Medical, Inc. (U.S.)
·
BioMed Central Ltd (U.K.)
·
Aevi Genomic Medicine, Inc. (Israel)
·
Congenica Ltd. (U.K.)
·
Deep Genomics (Canada)
·
Editas Medicine (U.S.)
·
Illumina, Inc. (U.S.)
·
Thermo Fisher Scientific Inc. (U.S.)
Download
Sample PDF Copy of this Report to understand structure of the complete report @
https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-genome-editing-market
TABLE OF
CONTENTS:
Part 01: Executive Summary
Part 02: Scope of the Report
Part 03: Research Methodology
Part 04: Market Landscape
Part 05: Pipeline Analysis
Part 06: Market Sizing
Continue………
Browse
Trending Reports:
·
Global Precision Medicine Market
·
Global Traumatic Brain Injuries Treatment
Market
About
Data Bridge Market Research:
An absolute way to predict what the future holds is to
understand the current trend! Data Bridge Market Research presented itself as
an unconventional and neoteric market research and consulting firm with an
unparalleled level of resilience and integrated approaches. We are committed to
uncovering the best market opportunities and nurturing effective information
for your business to thrive in the marketplace. Data Bridge strives to provide appropriate
solutions to complex business challenges and initiates an effortless
decision-making process. Data Bridge is a set of pure wisdom and experience
that was formulated and framed in 2015 in Pune.
Data Bridge Market Research has more than 500 analysts working
in different industries. We have served more than 40% of the Fortune 500
companies globally and have a network of more than 5,000 clients worldwide.
Data Bridge is an expert in creating satisfied customers who trust our services
and trust our hard work with certainty. We are pleased with our glorious 99.9%
customer satisfaction rating.
Contact
Us: -
Data Bridge Market Research
US: +1 888 387 2818
United Kingdom: +44 208 089 1725
Hong Kong: +852 8192 7475
Email: – corporatesales@databridgemarketresearch.com
Comments
Post a Comment